Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Shifren

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Menopause (New York, N.Y.)|November 19, 2014
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trialBette Caan, Andrea Z LaCroix, Hadine Joffe, et al.
Fertility and Sterility|April 9, 2002
Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessmentGloria Bachmann, John Bancroft, Glenn Braunstein, et al.
JAMA Internal Medicine|May 28, 2014
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trialHadine Joffe, Katherine A Guthrie, Andrea Z LaCroix, et al.
Menopause (New York, N.Y.)|April 27, 2021
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiativeSarah Lensen, David Archer, Robin J Bell, et al.
Menopause (New York, N.Y.)|May 11, 2021
A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiativeSarah Lensen, Robin J Bell, Janet S Carpenter, et al.
Menopause (New York, N.Y.)|May 14, 2024
Recommended measurement instruments for genitourinary symptoms associated with menopause: the COMMA (Core outcomes in menopause) consortiumVincent S Paramanandam, Sarah Lensen, Michaela Gabes, et al.
Menopause (New York, N.Y.)|April 30, 2024
Recommended measurement instruments for menopausal vasomotor symptoms: the COMMA (Core Outcomes in Menopause) consortiumSarah Lensen, Vincent S Paramanandam, Michaela Gabes, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Menopause (New York, N.Y.)|November 19, 2014
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trialBette Caan, Andrea Z LaCroix, Hadine Joffe, et al.
Fertility and Sterility|April 9, 2002
Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessmentGloria Bachmann, John Bancroft, Glenn Braunstein, et al.
JAMA Internal Medicine|May 28, 2014
Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trialHadine Joffe, Katherine A Guthrie, Andrea Z LaCroix, et al.
Menopause (New York, N.Y.)|April 27, 2021
A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiativeSarah Lensen, David Archer, Robin J Bell, et al.
Menopause (New York, N.Y.)|May 11, 2021
A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiativeSarah Lensen, Robin J Bell, Janet S Carpenter, et al.
Menopause (New York, N.Y.)|May 14, 2024
Recommended measurement instruments for genitourinary symptoms associated with menopause: the COMMA (Core outcomes in menopause) consortiumVincent S Paramanandam, Sarah Lensen, Michaela Gabes, et al.
Menopause (New York, N.Y.)|April 30, 2024
Recommended measurement instruments for menopausal vasomotor symptoms: the COMMA (Core Outcomes in Menopause) consortiumSarah Lensen, Vincent S Paramanandam, Michaela Gabes, et al.
Pageof 3